Prof. Dr. med. Mark Schrader
Chief Physician Urology at Helios Hospital Berlin-Buch
                                
                                    Helios Hospital Berlin-Buch
                                
                            Specialist fields (in extracts)
- All types of urological and andrological disorders
 - Bladder, penis, testicle and prostate cancer treatment
 - Minimally invasive kidney surgery
 - Focal brachitherapy
 - Hot steam prostate treatment (Rezum)
 - Removal of concrements and neoplasms from kidneys, bladder and urinary tract in general
 
Curriculum vitae (in extracts)
| 1987 – 1993 — Johannes Gutenberg University Mainz (Germany) — general medicine
				 | 
		
| 1992 – Harvard Medical School (USA) — cardiovascular surgery
				 | 
		
| 1993 – Boston University (USA) — urology and general surgery | 
| 1994 – PhD dissertation in medicine, Johannes Gutenberg University, Mainz
				 | 
		
| Since 2003 — Teaching assistant professor of urology, Charite University Medical School
				 | 
		
| 2003 – 2004 — Senior physician, Urology, Benjamin Franklin Campus. Free University of Berlin
				 | 
		
| 2004 – 2007 — Senior physician and head of urology, Charité University Clinic
				 | 
		
| 2004 – 2009 — Teaching urology, Charité School of Medicine (Benjamin Franklin and Mitte)
				 | 
		
| Since 2010 — Visiting professor, department of urology, Ulm University Clinic
				 | 
		
| Since 2014 — Head of urology at Helios Berlin-Buch
				 | 
		
Academic activities
| 
				 Authored 120 research papers. Some of the most prominent are listed below:  | 
		
| 
				 - «Vinflunine maintenance treatment following first-line therapy of advanced urothelial carcinoma» (2015)  | 
		
| 
				 - «Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations» (2014)  | 
		
| 
				 - «Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size» (2014)  | 
		
| - «Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer» (2012)
				 | 
		
Contributions
| 
				 German Urology Society  | 
		
| 
				 European Association of Urology  | 
		
| 
				 Urologic Oncology Association (board member)  | 
		
| German Society of Ultrasound in Medicine and Biology
				 | 
		
Send Request
We speak Arabic, English, French, German and Russian